Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

CLARITHROMYCIN 500 MG- clarithromycin tablet, film coated

  1. Provide The Following Instructions Or Information About Clarithromycin Tablets To Patients:
  2. Manufactured By:
  3. Distributed By:
  4. Patient Information

Provide The Following Instructions Or Information About Clarithromycin Tablets To Patients: 

  • Counsel patients that antibacterial drugs including clarithromycin tablets should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When clarithromycin tablets are prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by clarithromycin tablets or other antibacterial drugs in the future.
  • Advise patients that diarrhea is a common problem caused by antibacterials including clarithromycin tablets which usually ends when the antibacterial is discontinued. Sometimes after starting treatment with antibacterials, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibacterial. If this occurs, instruct patients to contact their healthcare provider as soon as possible.
  • Advise patients that clarithromycin tablets may interact with some drugs; therefore, advise patients to report to their healthcare provider the use of any other medications.
  • Advise patients that clarithromycin tablets can be taken with or without food and can be taken with milk.
  • There are no data on the effect of clarithromycin tablets on the ability to drive or use machines. However, counsel patients regarding the potential for dizziness, vertigo, confusion and disorientation, which may occur with the medication. The potential for these adverse reactions should be taken into account before patients drive or use machines.
  • Advise patients that if pregnancy occurs while taking this drug, there is a potential hazard to the fetus [see Warnings and Precautions (5.7) and Use in Specific Populations (8.1)].
  • Advise patients who have coronary artery disease to continue medications and lifestyle modifications for their coronary artery disease because clarithromycin may be associated with increased risk for mortality years after the end of clarithromycin treatment.

The brands listed are trademarks of their respective owners and are not trademarks of Jubilant Cadista Pharmaceuticals Inc. The makers of these brands are not affiliated with and do not endorse Jubilant Cadista Pharmaceuticals Inc. or its products.

Manufactured By: 

Vivimed Life Sciences Private Limited
Plot No.101, 102, 107 & 108,
SIDCO Pharmaceutical Complex,
Alathur, Kanchipuram Dist 603 110,
Tamilnadu, India.

Distributed By: 

Jubilant Cadista Pharmaceuticals Inc.
Salisbury, MD 21801, USA.

Patient Information 

Sections or subsections omitted from the full prescribing information are not listed.

Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: